TS
GILD icon

Triglav Skladi’s Gilead Sciences GILD Stock Holding History

Triglav Skladi’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.23M Sell
16,000
-4,387
-22% -$614K 0.16% 81
2025
Q4 		$2.5M Buy
20,387
+4,387
+27% +$533K 0.16% 83
2025
Q3 		$1.78M Hold
16,000
– – 0.12% 84
2025
Q2 		$1.77M Hold
16,000
– – 0.13% 85
2025
Q1 		$1.79M Hold
16,000
– – 0.15% 77
2024
Q4 		$1.48M Buy
+16,000
New +$1.44M 0.12% 89

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Triglav Skladi's GILD Position: Q1 2026 in Review

Triglav Skladi reduced its Gilead Sciences (GILD) stake by 22% in Q1 2026, selling an estimated $614K and leaving 16,000 shares worth $2.23M. The position accounts for 0.16% of the portfolio, ranked #81.

Triglav Skladi first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.5M in Q4 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Triglav Skladi held 16,000 shares of Gilead Sciences worth $2.23M as of Q1 2026.
  • Triglav Skladi sold 4,387 Gilead Sciences shares in Q1 2026, an estimated $614K.
  • Gilead Sciences made up 0.16% of Triglav Skladi's portfolio in Q1 2026, its #81 holding.
  • Triglav Skladi first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • Triglav Skladi's Gilead Sciences position peaked at $2.5M in Q4 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Triglav Skladi's 13F filing for Q1 2026, filed 4 May 2026.